Abstract
Mammalian cell cultures are the preferred production system for secreted pharmaceutical proteins (Hauser, 1997). Life of a mammal begins with fertilization of the oocyte that divides and proliferates until the animal reaches its mature size. Further cell growth is tightly controlled. Proliferation and cell death are balanced to keep the total cell mass essentially constant, while the synthesis and secretion of cellular products continues. Despite rapid progress in the understanding of growth regulatory mechanisms, tumorigenic growth due the loss of proliferation control of a single body cell initially is still a leading cause of disease and death.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Al-Rubeai, M., Emery, A.N., Chalder, S. and Jan, D.C. (1992) Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures, Cytotechnology 9. 85–97.
Au, W.C.. Moore, P.A.. LaFleur, D.W., Tombal, B., Pitha, P.M. (1998) Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes.. J. Mol. Chem. 273, 29210–7.
Bebbington. C.R., Renner, G., Thomson, S., King, D., Abrams, D., Yarranton, G.T., (1992) High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology 10, 169.
Benech, P.. Vigneron, M., Peretz, D. Revel, M., Chebath, J. (1987) Interferon-responsive regulatory elements in the promoter of the human 2′,5′-oligo(A) synthetase gene. Mol. Cell. Biol. 7, 4498–504.
Boultwood, J., Fidler, C. Lewis, S.. MacCarthy, A.. Sheridan, H., Kelly, S, Oscier, D., Buckle. V.J., Wainscoat, J.S. (1993) Allelic loss of IRFI in myelodysplasia and acute myeloid leukemia: retention of IRFI on the 5q-chromosome in some patients with the 5q-syndrome. Blood 82, 2611–6.
Carvalhal, AV. Moreira, J.L.. Müller, P.P., Hauser, H.. and Carrondo, M.J.T. (1998) Cell growth inhibition by the IRF-1 system, in New developments and new applications in animal cell technology (Merten, O.-W., Perrin, P, and Griffiths, B., eds.) Kluwer Academic Publishers, pp. 215–217.
Chang, C.H., Hammer, J., Loh, J.H., Fodor, W.L., Flavell, R.A. (1992) The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1), Immunogenetics 35, 378–384.
Clemens, M.J. (1997) PKR-a protein kinase regulated by double-stranded RNA. Int. J. Biochem. Cell. Biol. 29, 945–949
Cockett, M.I. Bebbington, C.R., Yarranton, G.T. (1990) High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification. Biotechnology 8, 662–667.
Fibi, MR.. Hermentin, P., Pauly, J.U., Lauffer, L. and Zettlmeissl, G. (1995) N-and O-glycosylation muteins of recombinant human erythropoietin secreted from BHK-21 cells, Blood 85, 1229–1236.
Fujita, T., Sakakibara, J., Sudo, Y., Miyamoto, M., Kimuia, Y. and Taniguchi, T. (1988) Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements EMBOJ. 7, 3397–3405.
Fujita, T.. Kimura, Y., Miyamoto, M., Barsoumian, E. L. and Taniguchi, T. (1989) Induction of endogenous IFN-α and IFN-ß genes by a regulatory transcription factor, IRF-1, Nature 337, 270–272.
Fukuda, M.N.. Sasaki, H., Lopez. L. and Fukuda, M. (1989) Survival of recombinant erythropoietin in the circulation: the role of carbohydrates, Blood 73, 84–89.
Fussenegger, M., Mazur, X. and Bailey, J. E. (1997) A novel cytostatic process enhances the productivity of Chinese hamster ovary cells, Biotechnol. Bioeng. 55, 927–938.
Fussenegger, M., Schlatter, S., Datwyler, D., Mazur, X. and Bailey, J. E. (1998) Controlled proliferation by multigene metabolic engineering enhances the productivity of Chiese hamster ovary cells, Nat. Biotechnol. 16, 468–472.
Fussenegger, M., Bailey, J.. Hauser, H. and Mueller, P.P. (1999) Genetic Optimization of Recombinant Protein Production by Mammalian Cells, TIBTECH 17, 43–50.
Gawlitzek, M.. Conradt, H. S. and Wagner, R. (1995) Effect of different cell culture conditions on the polypeptide integrity and N-glycosylation of a recombinant model glycoprotein, Biotecnol. Bioeng. 46, 536–544.
Gawlitzek, M., Valley, U., Wagner, R. (1998) Ammonium ion/glucosamine dependent increase of oligosaccharide complexity in recombinant glycoproteins secreted from cultivated BHK-21 cells, Biotechnol. Bioeng. 57, 518–528.
Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters, Proc. Natl. Acad. Sci. USA 89, 5547–5551.
Gossen, M., Freundlieb, S., Bender, G., Müller, G, Hillen, W. and Bujard, H. (1995) Transcriptionai activation by tetracyclines in mammalian cells., Science 268, 1766–1769.
Goto, M., Akai, K., Murakami, A., Hashimoto, C., Tsuda, E., Ueda, M., Kawanishi, G., Takahashi, N., Ishimoto A., Chiba, H. and Sasaki, R. (1988). Production of recombinant human erythropoietin in mammalian cells: Host-cell dependency of the biological activity of the cloned glycoprotein, Bio/Technology 6, 67–71.
Grabenhorst, E., Hoffmann, A., Nimtz, M., Zetthneissl, G. and Conradt, H. S. (1995). Construction of stable BHK-21 cells expressing human secretory glycoproteins and human Gal(βl-4)GlcNAc-R α2,6-sialyltransferase. α2,6-linked NeuAc is preferentially attached to the Gal(βl-4)GlcNAc(βl-2)Man(αl-3)-branch of diantennary oligosaccharides from secreted recombinantß-trace protein, Eur.J. Biochem. 232, 718–725.
Graham, F. and v. der Eb, L. (1973) A new technique for the assay of infectivity of human adenovirus DNA, Virology 52. 456–487.
Gramer, M. J. and Goochee, C. F. (1990) Glycosidase activities in Chinese hamster ovarycell lysate and cell culture supernatant, Biotechnol. Prog. 9, 366–373.
Gramer, M. J., Goochee, C.F., Chock, V.Y., Brousseau, D.T. and Sliwkowsky, M.B. (1995) Removal of sialic acid from a glycoprotein in CHO cell culture supernatant by action of an extracellular CHO cell sialidase, Bio/Technology 13, 692–698.
Grammatikos, S. I., Valley, U.. Nimtz, M., Conrad, H. S., Wagner, R. (1998) Intracellular UDP-N-acetyl-hexosamine pool affects N-glycan complexity: A mechanism of anmonium action on protein glycosylation, Biotechnol. Progr. 14, 410–419.
Harada, H., Fujita, T.. Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T. and Taniguchi, T. (1989) Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes, Cell 58, 729–739.
Harada, H., Willison, K., Sakakibara, J., Miyamoto, M., Fujita, T. and Taniguchi, T. (1990) Absence of the type I IFN system in EC cells: Transcriptionai activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63, 303–312.
Harada, H.. Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M. and Taniguchi, T. (1993) Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and-2, Science 259, 971–974.
Hassel, B.A., Zhou, A., Sotomayor, C., Maran, A., Silverman, R.H. (1993) A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviraleffects of interferon, EMBO J. 12, 3297–304.
Hauser, H.: Heterologous expression of genes in mammalian cells. (1997) In: Mammalian Cell Biotechnology in Protein Production. (H. Hauser and R. Wagner, eds.) De Gruyter, Berlin, pp. 1–32.
Jacobsen, H.. Czamiecki, C.W., Krause, D., Friedman, R.M. and Silverman, R.H. (1983) Interferon-induced synthesis of 2-5A-dependent RNase in mouse JLS-V9R cells. Virology 125, 496–501.
Jenkins, N.. Parekh, R. B. and James, D. C. (1996) Getting the glyosylation right: implications for the biotechnological industry, Nat. Biotechnol. 14, 975–981.
Kim, Y.H., lida, T., Fujita, T., Terada, S., Kitayama, A., Ueda, H., Prochownik, E.V. and Suzuki, E. (1998) Establishment of an apoptosis-resistant and growth-controllable cell line by transfecting with inducible antisense c-Jun gene, Biotechnol. Bioeng. 58, 65–72.
Kimura, T., Nakayama, K., Penninger, J., Kitagawa, M., Harada, H., Matsuyama, T., Tanaka, N., Kamijo, R., Vilcek, J., Mak, T.W. et al. (1994) Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264, 1921–1924.
Kirchhoff, S., Schaper, F. and Hauser, H. (1993) Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes, Nucleic Acids Res. 21, 2881–2889.
Kirchhoff, S.. Koromilas, A. E., Schaper, F., Grashoff, M., Sonenberg, N. and Hauser, H. (1995) IRF-1 induced cell growth inhibition and interferon induction requires the activity ofthe protein kinase PKR. Oncogene 11. 439–445.
Kirchhoff, S., Kröger, A., Cruz, H., Tümmler, M., Schaper, F., Köster, M. and Hauser, H. (1996) Regulation of cell growth by IRF-1 in BHK-21 cells. Cytotechnology 22, 147–156.
Kirchhoff, S.. Schaper, F., Oumard, A. and Häuser, H. (1998) In vivo formation of IRF-1 homodimers, Biochimie, in press.
Kirchhoff, S. and Hauser, H. (1999a) Cooperative activity between HER oncogenes and the tumor suppressor of IRF-1 results in apoptosis. Oncogene. in press.
Kirchhoff, S., Wilhelm, D., Angel, P. and Hauser, H. (1999b) NF-kB activation is required for IRF-1 mediated IFN-induction. Europ. J. of Biochem., in press.
Köster, M., Kirchhoff, S., Schaper, F. and Häuser, H. (1995) Proliferation control of mammalian cells by the tumor suppressor IRF-1, in Animal Cell Technology: Developments towards the 21st Century (Beuvery, Griffiths. Zeijlemaker. eds.) Kluwer Academic Publishers, pp. 33–44.
Koromilas, A.E., Roy, S., Barber, G.N., Katze, M.G. and Sonenberg (1992) Malignant transformation bya mutant of the IFN-inducible dsRNA-dependent protein kinase, Science 257, 1685–1689.
Kuhen, K.L., Vessey, J.W. and Samuel, C.E. (1998) Mechanism of interferon action: identification of essential positions within the novel 15-base-pair KCS element required for transcriptional activation of the RNA-dependent protein kinase pkr gene, J. Virol. 72, 9934–9939.
Lee, S.B. and Esteban, M. (1993) The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. Virology 193, 1037–1041.
Lengyel, P. (1993) Tumor-suppressor genes: news aboutthe interferon connection Proc. Natl. Acad. Sci. USA, 90. 5893–5895.
Lin, R.. Mustafa, A., Nguyen, H., Gewert, D. and Hiscott, J. (1994) Mutational analysis of interferon (IFN) regulatory factors I and 2. J. Biol. Chem. 269, 17542–17549
Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kündig, T.M., Amakawa, R., Kishihara, K., Wakeham, A., Potter, J., Furlonger, C.L., Narendran, A., Suzuki, H., Ohashi, P.S., Paige, C.J., Taniguchi, T. and Mak, T.W. (1993) Target disruption of IRF-1 or IRF-2 results in abnormal type1 IFN gene induction and aberrant lymphocyte development, Cell 75, 83–97.
Mazur, X.. Fussenegger, M., Renner, W.A. and Bailey, J.E. (1998) Higher productivity of growth-arrested Chinese hamster ovary cells expressing the cyclin-dependent kinase inhibitor p27, Biotechnol. Prog. 14. 705–713.
Mitchell, C.A.. Beall, J.A.. Wells, J.R., Gray, P.P. (1991) Growth and protein production kinetics of a murine myeloma cell line transfected with the human growth hormone gene, Cytotechnology 5, 2232–31.
Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M.. Harada, H., Sudo, Y., Miyata, T. and Taniguchi, T. (1988) Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-gene regulatory elements, Cell 54. 903–913.
Mueller, P. P., Kirehhoff, S. and Hauser, H. (1998) in New Developments and New Applications in Animal Cell Technology (Merten, O.W., Perrin, P. and Griffiths, J.B., eds) Kluwer Academic Publishers, pp. 209–213.
Mueller, P.P.. Schlenke, P.. Nimtz, M., Conradt, H.S. and Hauser, H. (1999). Recombinant glycoprotein product quality in proliferation controlled BHK-21 cells. Submitted.
Munzert, E.. Heidemann, R., Büntemeyer, H., Lehmann, J. and Müthing, J. (1998) Production of recombinant human antithrombin III on 20-1 bioreactor sale: Correlation of supernatant neuraminidase activity, desialylation. and decrease of biological activity of recombinant glycoprotein, Biotechnol. and Bioeng. 56, 441–447.
Pendse, G.J., Karkare, S. and Bailey, J.E. (1992) Effect of cloned gene dosage on cell growth and hepatitisB surface antigen synthesis and secretion in recombinant CHO cells, Biotechnol. Bioeng. 40. 119–129.
Pine, R., Decker, T.. Kessler, D.S.. Levy, D.E. and Darnell Jr., J.E. (1990) Purification and cloning of interteron-stimulated gene factor 2 (ISGF2): 1SGF2 (IRF-1) can bind to the promoters of both beta interferon-and interteron-stimulated genes but is not a primary transcriptonal activator of either. Mol. Cell. Biol. 10, 2448–2457.
Pine, R. (1992) Constitutive expression of an ISGF2/IRF1 transgene leads to interferon independent activation of interferon-inducible genes and resistance to virus infection, J. Virol. 66, 4470–4478.
Raveh, T., Hovanessian, A.G., Meurs, E.F., Sonenberg, N. and Kimchi, A. (1996) Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons J. Biol. Chem. 271, 25479–15484.
Reich, N.C., Darnell, J.E. Jr (1989) Differential binding of interferon-induced factors to an oligonucleotide that mediates transcriptional activation, Nucleic Acids Res. 17, 3415–3424.
Reis, L.F.L.. Ruffner, H., Stark, G., Aguet, M. and Weissmann, C. (1994) Mice devoid of IRF-1 show normal expression of type 1 IFN genes. EMBO J. 13. 4798–4806.
Reis, L.R.L.. Harada, H.. Wolchok, J. D., Taniguchi, T. and Vilcek, J. (1992) Critical role of a common transcription factor, IRF-1. in the regulation of IFN-and IFN-inducible genes, EMBO J. 11. 185–193.
Robinson, D.K.. Memmert, K.W. (1991) Kinetics of recombinant iinmunoglobulin production by mammalian cells in continuous culture, Biotechnol. Bioeng. 38, 972–976.
Samuel, C.E. (1998) Reoviruses and the interferon system, Curr Top. Microbiol. Immunol. 233, REOVIR.II, 125–145.
Schaper, F., Kirchhoff, S., Posern, G., Koester, M., Oumard, A., Sharf, R., Levi, B.Z. and Hauser, H. (1998) Functional domains of interferon regulatory factor I (IRF-1), Biochem. J. 335, 147–157.
Smiley, A.L., Hu, W.S. and Wang, D.I.C. (1989) Production of human immune interferon by recombinant mammalian cells cultivated on microcarriers Biotechnol. Bioeng. 33, 1181–1190.
Srivastava, S.P., Kumar, K.U. and Kaufman, R.J. (1998) Phosphorylation of eukaryotic translation initiation factor mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase, J. Biol. Chem. 23,273, 2416–2423.
Stevens, A.M., Yu-Lee, L. (1992) The transcription factor interferon regulatory factor-I is expressed during both early GI and the Gl/S transition in the prolactin-induced lymphocyte cell cycle, Mol Endocrinol. 6, 2236–43.
Suzuki, E. and Ollis, D.E. (1990) Enhanced antibody production at slowed growth rates: experimental demonstration and asimple structured model, Biotechnol. Prog. 6, 231–236.
Tan, R.A., Taniguchi, T. and Harada, H. (1996) Identification of the lysyl oxidase gene as target of the anti oncogenic transcription factor, IRF-1, and its possible role in tumor suppression, Cancer Res. 56, 2417–2421.
Tanaka, N.. Kawakami, T., Taniguchi, T. (1993) Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system, Mol. Cell. Biol. 13, 4531–4538.
Tanaka, H. and Samuel, C.E. (1994) Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase, Proc. Natl. Sci. USA 91, 7995–7999.
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T.. Matsuyama, T., Lamphier, M. C., Aizawa, S., Mak, T. W. and Taniguchi, T. (1994) Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1, Cell 77, 829–839.
Tanaka, N., Ishihara, M., Lamphier, M.S., Nozawa, H., Matsuyama, T., Mak, T.W., Aizawa, S., Tokino, T., Oren, M. and Taniguchi, T. (1996) Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382, 816–818.
Tonouchi, N., Koyama, N, Miwa, A. (1992) CHO strain producing high-level human IL-6 with the 3′ deletion construct,. J. Biotechnol. 22, 283–289.
Tsao, E.I., Bonn, M.A., Omstead, D.R., Munster, M..J. (1992) Optimization of a roller bottle process for the production of recombinant erythropoietin, Ann. N. Y. Acad. Sci. 665, 127–136.
Uegaki, K., Shirakawa, M., Harada, H., Taniguchi, T. and Kyogoku, Y. (1995) Secondary structure and folding topology of the DNA binding domain of interferon regulatory factor 2, as revealed by NMR spectroscopy, FEBS Lett. 359, 184–188.
Yim, J.H., Wu, S.J.. Casey M.J.. Norton, J.A. and Doherty, G.M. (1997) IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice. J. Immunol. 158, 1284–1292.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic Publishers
About this chapter
Cite this chapter
Mueller, P.P. et al. (1999). Development of an IRF-1 Based Proliferation Control System. In: Al-Rubeai, M. (eds) Cell Engineering. Cell Engineering, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-37971-5_8
Download citation
DOI: https://doi.org/10.1007/978-0-585-37971-5_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-5790-2
Online ISBN: 978-0-585-37971-5
eBook Packages: Springer Book Archive